Top Poster Recognition for AI-Powered Diagnostics at Roche’s UK Showcase

Singapore, September 17, 2024 — Qritive recently took part in Roche’s 3rd Annual Hybrid Digital Pathology and AI Showcase held in the United Kingdom. The event brought together leaders, innovators, and key stakeholders from across the digital pathology and artificial intelligence ecosystem.

During the event, our team presented how Qritive’s AI-powered digital pathology solutions are helping to enhance diagnostic accuracy and streamline laboratory workflows across the globe. We are proud to share that our poster presentation was recognized as one of the top four at the showcase—an important milestone and a moment of recognition for our dedicated team.

We thank Roche for organizing such an impactful event and providing a platform to exchange ideas and explore future collaborations in the evolving field of AI in pathology. We look forward to continuing these valuable conversations.

About Qritive

Qritive, headquartered in Singapore with operations in the US and India, is transforming digital pathology through advanced AI-powered solutions that support cancer diagnosis and improve health outcomes.

By leveraging cutting-edge deep learning technology, Qritive supports pathologists in the interpretation of pathology assessments and enhances pathology workflows—enabling faster, more accurate diagnoses and reducing time to treatment.

Qritive is committed to empowering healthcare professionals around the world with tools that promote collaboration and high performance, regardless of complexity or distance.

Get in Touch

Want to learn more about our solutions or explore potential collaborations?

Visit www.qritive.com or contact us at info@qritive.com.